Myositis as an adverse event of immune checkpoint blockade for cancer therapy

We report six patients receiving ICIs who presented with de novo myositis.

Source: Seminars in Arthritis and Rheumatism - May 17, 2018 Category: Rheumatology Authors: Mohsin Shah, Jean H. Tayar, Noha Abdel-Wahab, Maria E. Suarez-Almazor Source Type: research